Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Исследование стабильности полярной формулы Бреннера–Пфлюгера как маркера рефрактерности к ботулиническому токсину типа А
________________________________________________
Zhuchkov M.V., Zhil'tsova E.E., Bol'shakova E.E. et al. Study of stability of the polar formula of Brenner–Pfluger as a refracter marker to botulinic toxin type A. Consilium Medicum. 2019; 21 (12.2): 42–45. DOI: 10.26442/24143537.2019.2.190403
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Ключевые слова: ботулинический токсин, мимические морщины, полярная формула Бреннера–Пфлюгера.
________________________________________________
The article presents the results of the innovative work of the team of authors on the development of a method for noninvasive early diagnostics of refractory to botulinum toxin type A, used to correct facial wrinkles in patients suffering from actinic elastosis, high grades according to R. Glogau.
Key words: botulinum toxin, mimic wrinkles, polar Brenner–Pfluger formula.
2. Álvaro-González LC et al. Botulinum toxin A in chronic refractory migraine: premarketing experience. Rev Neurol 2012; 55 (7): 385–91.
3. Wu DC, Fabi SG, Goldman MP. Neurotoxins: Current Concepts in Cosmetic Use on the Face and Neck-Lower Face. Plast Reconstr Surg 2015; 136 (Suppl. 5): 76–9.
4. Cavallini M. Preliminary Report on an Objective, Fast, and Reproducible Method to Measure the Effectiveness of Botulinum Toxin Type A. Aesthet Surg J 2015; 35 (6): 715–20.
5. Sapra P et al. A Single-blind, Split-face, Randomized, Pilot Study Comparing the Effects of Intradermal and Intramuscular Injection of Two Commercially Available Botulinum Toxin A Formulas to Reduce Signs of Facial Aging. J Clin Aesthet Dermatol 2017; 10 (2): 34–44.
6. Carruthers A et al. Repeated botulinumtoxin. A Treatment of Glabellar Lines at Rest Over Three Treatment Cycles. Dermatol Surg 2016; 42 (9): 1094–1101.
________________________________________________
1. Stephan F, Habre M, Tomb R. Clinical resistance to three types of botulinum toxin type A in aesthetic medicineю. J Cosmetic Dermatology 2014; 13 (4): 346–8.
2. Álvaro-González LC et al. Botulinum toxin A in chronic refractory migraine: premarketing experience. Rev Neurol 2012; 55 (7): 385–91.
3. Wu DC, Fabi SG, Goldman MP. Neurotoxins: Current Concepts in Cosmetic Use on the Face and Neck-Lower Face. Plast Reconstr Surg 2015; 136 (Suppl. 5): 76–9.
4. Cavallini M. Preliminary Report on an Objective, Fast, and Reproducible Method to Measure the Effectiveness of Botulinum Toxin Type A. Aesthet Surg J 2015; 35 (6): 715–20.
5. Sapra P et al. A Single-blind, Split-face, Randomized, Pilot Study Comparing the Effects of Intradermal and Intramuscular Injection of Two Commercially Available Botulinum Toxin A Formulas to Reduce Signs of Facial Aging. J Clin Aesthet Dermatol 2017; 10 (2): 34–44.
6. Carruthers A et al. Repeated botulinumtoxin. A Treatment of Glabellar Lines at Rest Over Three Treatment Cycles. Dermatol Surg 2016; 42 (9): 1094–1101.
1 ГБУ РО «Областной клинический кожно-венерологический диспансер», Рязань, Россия;
2 ФГБОУ ВО «Рязанский государственный медицинский университет им. акад. И.П. Павлова» Минздрава России, Рязань, Россия
*misha.juchkov@gmail.com
________________________________________________
M.V. Zhuchkov*1, E.E. Zhil'tsova2, E.E. Bol'shakova1, D.B. Sonin1, O.V. Zverkova1, S.A. Rodionova1, M.S. Isakova1
1 Ryazan State Regional Dermato-Venerological Clinic, Ryazan, Russia;
2 I.P. Pavlov Ryazan State Medical University of the Ministry of Health of the Russian Federation, Ryazan, Russia
*misha.juchkov@gmail.com